Macrocyclics player PeptiDream rockets after Japan IPO
This article was originally published in Scrip
Executive Summary
Early investors in PeptiDream must be pinching themselves to make sure it's real. Shares in the Japanese drug discovery venture have gone through the roof since its initial public offering on the Mothers high-tech market of the Tokyo Stock Exchange earlier this week.